OPKO Health Stock

OPKO Health EBIT

The EBIT of OPKO Health (OPK) as of Aug 14, 2026 is -147.74 M USD. In the previous year, EBIT was -152.07 M USD — a change of -2.84% (higher).

EBIT

-147.74 MUSD

YoY

-2.84%

Last updated:

In 2026, OPKO Health's EBIT was -147.74 M USD, a -2.84% increase from the -152.07 M USD EBIT recorded in the previous year.

The OPKO Health EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2023
-175.29 base
Jan 1, 2024
-152.07 base
Jan 1, 2025
-147.74 base
Jan 1, 2026 (e)
-79.44 base
Jan 1, 2027 (e)
-83.74 base
Jan 1, 2028 (e)
-89.68 base
Jan 1, 2029 (e)
-96.15 base
Jan 1, 2030 (e)
-103.36 base
YEAREBIT (M USD)
2030 est -103.36
2029 est -96.15
2028 est -89.68
2027 est -83.74
2026 est -79.44
2025 -147.74
2024 -152.07
2023 -175.29
2022 -379.47
2021 18.75
2020 57.71
2019 -283.45
2018 -166.62
2017 -276.44
2016 -89.39
2015 -98.50
2014 -145.80
2013 -79.63
2012 -37.27
2011 -23.19
2010 -11.14
2009 -22.82
2008 -37.17
2007 -267.86
2006 -1.12
Access this data via the Eulerpool API

OPKO Health Revenue

OPKO Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
863.50 M USD
-175.29 M USD
-188.86 M USD
Jan 1, 2024
713.14 M USD
-152.07 M USD
-53.22 M USD
Jan 1, 2025
606.88 M USD
-147.74 M USD
-225.68 M USD
Jan 1, 2026 (e)
536.80 M USD
-79.44 M USD
-227.84 M USD
Jan 1, 2027 (e)
565.85 M USD
-83.74 M USD
-219.08 M USD
Jan 1, 2028 (e)
605.95 M USD
-89.68 M USD
-71.36 M USD
Jan 1, 2029 (e)
649.70 M USD
-96.15 M USD
-135.20 M USD
Jan 1, 2030 (e)
698.40 M USD
-103.36 M USD
-120.18 M USD

OPKO Health Margins

OPKO Health stock margins

The OPKO Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of OPKO Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for OPKO Health.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
36.84 %
-20.30 %
-21.87 %
Jan 1, 2024
43.61 %
-21.32 %
-7.46 %
Jan 1, 2025
21.10 %
-24.34 %
-37.19 %
Jan 1, 2026 (e)
21.10 %
-14.80 %
-42.44 %
Jan 1, 2027 (e)
21.10 %
-14.80 %
-38.72 %
Jan 1, 2028 (e)
21.10 %
-14.80 %
-11.78 %
Jan 1, 2029 (e)
21.10 %
-14.80 %
-20.81 %
Jan 1, 2030 (e)
21.10 %
-14.80 %
-17.21 %

OPKO Health Stock analysis

What does OPKO Health do? OPKO Health Inc is an American company specializing in diagnostics, biopharmaceuticals, and pharmaceutical products. It was founded in 1991 by Dr. Phillip Frost, who still serves as CEO. The company is headquartered in Miami, Florida, and employs around 6,000 people worldwide. In recent years, OPKO Health Inc has undergone strong expansion, particularly through several acquisitions of other companies. These include Bio-Reference Laboratories, Inc., a leading provider of diagnostic services, and EirGen Pharma, a European company specializing in the production of high-quality pharmaceuticals. The business model of OPKO Health Inc is based on the development and marketing of products and services in the field of diagnostics and medical research. The company operates numerous state-of-the-art laboratories worldwide, which conduct diagnostic tests, genetic analyses, and medical research. OPKO Health Inc offers a wide range of products and services distributed across multiple business areas. One important area is the diagnostics division, which offers a wide range of tests and services, including cancer diagnostics, blood tests, genetic analyses, and clinical trials. Another important business area of OPKO Health Inc is the biopharmaceutical division, which focuses on the development and marketing of innovative therapies and medical products. The company develops medications against cancer and other diseases, as well as vaccines and immunological therapies. A third important business area of OPKO Health Inc is the pharmaceutical products division, which specializes in the production and distribution of pharmaceutical products and generic medications. The company has a broad portfolio of products, ranging from over-the-counter painkillers to medications for rare diseases. One of OPKO Health Inc's key products is the 4Kscore test, a blood test for diagnosing prostate cancer. This test is approved in the US and Europe and has a high accuracy rate in detecting aggressive forms of cancer. Another important product of the company is Rayaldee-Tabs, an innovative vitamin D medication used for the treatment of patients with chronic kidney disease (CKD). The medication has shown high efficacy in clinical studies and is currently approved in the US and Europe. OPKO Health Inc has become a significant player in the field of medical research and diagnostics through strong expansion and numerous acquisitions in recent years. The company focuses on high quality and innovative technologies to best support its customers worldwide. OPKO Health is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing OPKO Health's EBIT

OPKO Health's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of OPKO Health's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

OPKO Health's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in OPKO Health’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about OPKO Health stock

EBIT of OPKO Health is -147.74 M USD in 2026.

EBIT of OPKO Health changed from -152.07 M USD to -147.74 M USD, representing a -2.84% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT OPKO Health since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's OPKO Health historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — OPKO Health

All Key Metrics — OPKO Health